Effect of Food and Age on the Pharmacokinetics of LY03017 Trial Phase 1 Not yet recruiting Jan. 26, 2025
Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease Trial N/A Not yet recruiting Jan. 23, 2025
Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies Trial N/A Completed Jan. 22, 2025
Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training Trial N/A Completed Jan. 22, 2025
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation Trial Phase 1 Terminated Jan. 22, 2025
Effects of Gait Training With and Without PNF on Balance ,Gait and Activities of Daily Living in Parkinson's Patients Trial N/A Completed Jan. 22, 2025
Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease Trial N/A Recruiting Jan. 19, 2025
The Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease Trial N/A Active, not recruiting Jan. 16, 2025
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry Trial N/A Active, not recruiting Jan. 15, 2025
Comparative Effects of Alexander Techniques and Feldenkrais Method in Parkinson's Disease Trial N/A Enrolling by invitation Jan. 13, 2025
Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE) Trial N/A Enrolling by invitation Jan. 13, 2025
Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients Trial N/A Recruiting Jan. 13, 2025
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis Trial Phase 4 Completed Jan. 13, 2025
Development of a Multifunctional Rehabilitation Device for Persons With Parkinson's Disease Trial N/A Completed Jan. 13, 2025
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease Trial N/A Recruiting Jan. 12, 2025